# Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

> **NCT04190186** · NA · COMPLETED · sponsor: **University of Rochester** · enrollment: 55 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** Insertable Cardiac Monitor

## Key facts

- **NCT ID:** NCT04190186
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-25
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04190186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04190186, "Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04190186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*